CAR T cells: Building on the CD19 paradigm
Author:
Affiliation:
1. Immunology Lab Tel Aviv Sourasky Medical Center Tel Aviv Israel
2. Center for Cell Engineering Memorial Sloan Kettering Cancer Center New York NY USA
Publisher
Wiley
Subject
Immunology,Immunology and Allergy
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.202049064
Reference163 articles.
1. CAR therapy: the CD19 paradigm
2. CD19‐Targeted CAR T cells as novel cancer immunotherapy for relapsed or refractory B‐cell acute lymphoblastic leukemia;Davila M. L.;Clin Adv Hematol Oncol,2016
3. Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective
4. Chimeric Antigen Receptor Therapy
5. The T-body approach: potential for cancer immunotherapy
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Preclinical Evaluation of Novel Folate Receptor 1-Directed CAR T Cells for Ovarian Cancer;Cancers;2024-01-12
2. Early predictive factors of failure in autologous CAR T-cell manufacturing and/or efficacy in hematologic malignancies;Blood Advances;2024-01-11
3. In vivo human T cell engineering with enveloped delivery vehicles;Nature Biotechnology;2024-01-11
4. CAR‐Aptamers Enable Traceless Enrichment and Monitoring of CAR‐Positive Cells and Overcome Tumor Immune Escape;Advanced Science;2023-12-26
5. Fine-tuning the antigen sensitivity of CAR T cells: emerging strategies and current challenges;Frontiers in Immunology;2023-11-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3